CD4 and B-cell chronic lymphocytic leukemia: Hoffman et al., demonstrated that compared to healthy donors, CAR T cells derived from patients with CLL have significantly reduced expansion of CD4+ naïve CAR T cells, with increased expansion of PD-1+ CAR T cells.